The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria

ABSTRACT Members of the genus Mycobacterium are the most prevalent cause of infectious diseases. Mycobacteria have a complex cell envelope containing a peptidoglycan layer and an additional arabinogalactan polymer to which a mycolic acid bilayer is linked; this complex, multilayered cell wall compos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karin Schubert, Boris Sieger, Fabian Meyer, Giacomo Giacomelli, Kati Böhm, Angela Rieblinger, Laura Lindenthal, Nadja Sachs, Gerhard Wanner, Marc Bramkamp
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2017
Materias:
Acceso en línea:https://doaj.org/article/20eaefdb682943f8a062af6d59aa6b64
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:20eaefdb682943f8a062af6d59aa6b64
record_format dspace
spelling oai:doaj.org-article:20eaefdb682943f8a062af6d59aa6b642021-11-15T15:51:07ZThe Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria10.1128/mBio.02213-162150-7511https://doaj.org/article/20eaefdb682943f8a062af6d59aa6b642017-03-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02213-16https://doaj.org/toc/2150-7511ABSTRACT Members of the genus Mycobacterium are the most prevalent cause of infectious diseases. Mycobacteria have a complex cell envelope containing a peptidoglycan layer and an additional arabinogalactan polymer to which a mycolic acid bilayer is linked; this complex, multilayered cell wall composition (mAGP) is conserved among all CMN group bacteria. The arabinogalactan and mycolic acid synthesis pathways constitute effective drug targets for tuberculosis treatment. Ethambutol (EMB), a classical antituberculosis drug, inhibits the synthesis of the arabinose polymer. Although EMB acts bacteriostatically, its underlying molecular mechanism remains unclear. Here, we used Corynebacterium glutamicum and Mycobacterium phlei as model organisms to study the effects of EMB at the single-cell level. Our results demonstrate that EMB specifically blocks apical cell wall synthesis, but not cell division, explaining the bacteriostatic effect of EMB. Furthermore, the data suggest that members of the family Corynebacterineae have two dedicated machineries for cell elongation (elongasome) and cytokinesis (divisome). IMPORTANCE Antibiotic treatment of bacterial pathogens has contributed enormously to the increase in human health. Despite the apparent importance of antibiotic treatment of bacterial infections, surprisingly little is known about the molecular functions of antibiotic actions in the bacterial cell. Here, we analyzed the molecular effects of ethambutol, a first-line antibiotic against infections caused by members of the genus Mycobacterium. We find that this drug selectively blocks apical cell growth but still allows for effective cytokinesis. As a consequence, cells survive ethambutol treatment and adopt a pneumococcal cell growth mode with cell wall synthesis only at the site of cell division. However, combined treatment of ethambutol and beta-lactam antibiotics acts synergistically and effectively stops cell proliferation.Karin SchubertBoris SiegerFabian MeyerGiacomo GiacomelliKati BöhmAngela RieblingerLaura LindenthalNadja SachsGerhard WannerMarc BramkampAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 8, Iss 1 (2017)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Karin Schubert
Boris Sieger
Fabian Meyer
Giacomo Giacomelli
Kati Böhm
Angela Rieblinger
Laura Lindenthal
Nadja Sachs
Gerhard Wanner
Marc Bramkamp
The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria
description ABSTRACT Members of the genus Mycobacterium are the most prevalent cause of infectious diseases. Mycobacteria have a complex cell envelope containing a peptidoglycan layer and an additional arabinogalactan polymer to which a mycolic acid bilayer is linked; this complex, multilayered cell wall composition (mAGP) is conserved among all CMN group bacteria. The arabinogalactan and mycolic acid synthesis pathways constitute effective drug targets for tuberculosis treatment. Ethambutol (EMB), a classical antituberculosis drug, inhibits the synthesis of the arabinose polymer. Although EMB acts bacteriostatically, its underlying molecular mechanism remains unclear. Here, we used Corynebacterium glutamicum and Mycobacterium phlei as model organisms to study the effects of EMB at the single-cell level. Our results demonstrate that EMB specifically blocks apical cell wall synthesis, but not cell division, explaining the bacteriostatic effect of EMB. Furthermore, the data suggest that members of the family Corynebacterineae have two dedicated machineries for cell elongation (elongasome) and cytokinesis (divisome). IMPORTANCE Antibiotic treatment of bacterial pathogens has contributed enormously to the increase in human health. Despite the apparent importance of antibiotic treatment of bacterial infections, surprisingly little is known about the molecular functions of antibiotic actions in the bacterial cell. Here, we analyzed the molecular effects of ethambutol, a first-line antibiotic against infections caused by members of the genus Mycobacterium. We find that this drug selectively blocks apical cell growth but still allows for effective cytokinesis. As a consequence, cells survive ethambutol treatment and adopt a pneumococcal cell growth mode with cell wall synthesis only at the site of cell division. However, combined treatment of ethambutol and beta-lactam antibiotics acts synergistically and effectively stops cell proliferation.
format article
author Karin Schubert
Boris Sieger
Fabian Meyer
Giacomo Giacomelli
Kati Böhm
Angela Rieblinger
Laura Lindenthal
Nadja Sachs
Gerhard Wanner
Marc Bramkamp
author_facet Karin Schubert
Boris Sieger
Fabian Meyer
Giacomo Giacomelli
Kati Böhm
Angela Rieblinger
Laura Lindenthal
Nadja Sachs
Gerhard Wanner
Marc Bramkamp
author_sort Karin Schubert
title The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria
title_short The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria
title_full The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria
title_fullStr The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria
title_full_unstemmed The Antituberculosis Drug Ethambutol Selectively Blocks Apical Growth in CMN Group Bacteria
title_sort antituberculosis drug ethambutol selectively blocks apical growth in cmn group bacteria
publisher American Society for Microbiology
publishDate 2017
url https://doaj.org/article/20eaefdb682943f8a062af6d59aa6b64
work_keys_str_mv AT karinschubert theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT borissieger theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT fabianmeyer theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT giacomogiacomelli theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT katibohm theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT angelarieblinger theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT lauralindenthal theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT nadjasachs theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT gerhardwanner theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT marcbramkamp theantituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT karinschubert antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT borissieger antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT fabianmeyer antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT giacomogiacomelli antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT katibohm antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT angelarieblinger antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT lauralindenthal antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT nadjasachs antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT gerhardwanner antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
AT marcbramkamp antituberculosisdrugethambutolselectivelyblocksapicalgrowthincmngroupbacteria
_version_ 1718427386104512512